ArticleJournal of ovarian research2025
Development of a diagnostic model for ovarian cancer based on machine learning algorithms and functional analysis of key biomarker SOX17.
Article in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correction: Development of a diagnostic model for ovarian cancer based on machine learning algorithms and functional analysis of key biomarker SOX17.Journal of ovarian research · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
Abstract
backgroundOvarian cancer (OC) demonstrates the poorest prognosis among gynecological malignancies, with five-year survival rates below 45%, primarily due to late-stage diagnosis. To address this challenge, we systematically identified OC-specific differentially expressed genes (DEGs) to develop a robust diagnostic model based on eleven machine learning algorithms. Furthermore, we explored the potential mechanism of key DEG in OC.
methodsWe acquired RNA sequencing data of 426 tissues (352 °C tumor and 74 adjacent non-tumor) from the Gene Expression Omnibus (GEO) repository. Following rigorous batch effect correction and normalization procedures, DEGs were screened between tumor and non-tumor specimens. Furthermore, the resultant DEGs underwent comprehensive functional characterization, including Gene Ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, protein-protein interaction (PPI) network, and immune microenvironment analyses. To optimize diagnostic feature selection, we implemented a tiered analytical approach combining F-test, LASSO regression and Pearson correlation. The curated gene subset served as input for developing machine learning classifiers, with the cohort partitioned into stratified training (70%) and validation (30%) subsets. Eleven distinct algorithms were evaluated through iterative 10-fold cross-validation, with model performance quantified via receiver operating characteristic (ROC) analysis, precision-recall (PR) metrics, calibration curve fitting, learning curve profiling, and decision curve analysis (DCA) assessment. Finally, we investigated the biological functions of one key gene, SRY-box containing gene (SOX17) in OC cell lines by in vitro experiments.
resultsWe delineated 27 DEGs exhibiting distinct expression patterns in OC, with 16 upregulated and 11 downregulated genes. GO enrichment analysis suggested that DEGs were significantly enriched in response to folic acid, blood microparticle and alcohol dehydrogenase [NAD(P)+] activities. KEGG pathway analysis indicated that these DEGs were mainly involved in tyrosine metabolism, fatty acid degradation, ABC transporters and pyruvate metabolism. Immune microenvironment profiling revealed substantial M2 macrophage polarization and cytotoxic T-cell exhaustion in tumor tissues.The optimal diagnostic model was established based on five key genes (CD24, CLEC4M, SOX17, ADH1C and CHRDL1) and Logistic Regression algorithm was the optimal algorithm. The area under the receiver operating characteristic curve (AUC) and accuracy of the model were 0.93 and 0.875, respectively. SOX17 was upregulated in OC tumor tissues and knockdown of SOX17 obviously suppressed tumor cell proliferation and migratory.
conclusionOur multivariable diagnostic model based on five genes through logistic regression optimization, demonstrated robust discriminative capacity for OC. SOX17 functions as a suppressor and potential therapeutic target for OC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.